Our Leadership

In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.

In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.

Corporate Leadership

Ülo Palm
Secretary and Oversight Committee Chair, TransCelerate; Senior Vice President, Drug Development Operations, Allergan
Andy Lee
Treasurer, TransCelerate; Senior Vice President, Head of Global Clinical Trial Operations, Merck
Janice Chang
Senior Vice President, Global Operations, TransCelerate BioPharma, Inc.

Board of Directors

Dalvir Gill
Chief Executive Officer, TransCelerate BioPharma Inc.
Elliott Levy
Chair of the Board, Senior Vice President, Global Development, Amgen
David Nicholson
Vice Chair of the Board, Executive Vice President and Chief R&D Officer, Allergan
Roy Baynes
Senior Vice President, Global Clinical Development, Merck Research Laboratories
Sean Bohen
Executive Vice President, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
Christopher Corsico
Senior Vice President, Corporate Division Medicine and Chief Medical Officer, Boehringer Ingelheim GmbH
Anne Bording Jensen
Senior Vice President, Clinical Operations, Novo Nordisk A/S
Iris Loew-Friedrich
Executive Vice President and Chief Medical Officer, UCB
Rod MacKenzie
Executive Vice President, Chief Development Officer, Pfizer Inc.
Robert Metcalf
Vice President, Clinical Development Organization, Eli Lilly and Company
Kate Owen
Head of Global Clinical Operations (GCO), Bristol-Myers Squibb
John Reed
President, Global Research & Development, Sanofi
Alise Reicin
Senior Vice President, Head of Global Clinical Development, EMD Serono, Inc.
Michelle Rohrer
Senior Vice President, Global Head of Pharma Regulatory and Policy, Roche
Kathy Rouan
SVP and Head of Projects, Clinical Platforms and Sciences (PCPS), GSK
Takuko Sawada
Senior Executive Officer, Executive General Manager, Global Development, Shionogi & Co., Ltd.
Rob Scott
Chief Medical Officer, AbbVie
Badhri Srinivasan
Head, Global Development Operations, Novartis
Paul Stoffels
Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Bernhardt Zeiher
President, Global Development, Astellas Pharma